Biotech

Companies & Industries

Biotech Companies & Industries Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 04.01.2023.

#biotech
#lifesciences
#news
#pharma
#NBTintheNews
#RENE
#legal
#biospace

@BioWorld shared
On Dec 30, 2022
Boan Biotech nets almost $19.6M in Hong Kong IPO #biotech #pharma https://t.co/WMQfUWvMkt
Open
Boan Biotech nets almost $19.6M in Hong Kong IPO

Boan Biotech nets almost $19.6M in Hong Kong IPO

Boan Biotechnology Co. Ltd. raised HK$152.8 million (US$19.6 million) from a Hong Kong IPO, capital the company will use to speed up product development, expand marketing and ramp up ...

@Labiotech_eu shared
On Jan 3, 2023
Legend Biotech has announced that China’s NMPA has accepted its new drug application for ciltacabtagene autoleucel. 👇🏻 #biotech #lifesciences #news https://t.co/MRmcdkVk1M
Open
Legend Biotech new drug application approved in China

Legend Biotech new drug application approved in China

Legend Biotech has announced that China’s NMPA has accepted its new drug application for ciltacabtagene autoleucel.

@BiotechWorld shared
On Jan 3, 2023
Blacksmith Medicines Announces Merger With Forge Therapeutics to Create Leading Company Developing Medicines Targeting Metalloenzymes https://t.co/FTZcOhqtSc
Open
Blacksmith Medicines Announces Merger With Forge Therapeutics to Create Leading Company Developing Medicines Targeting Metalloenzymes

Blacksmith Medicines Announces Merger With Forge Therapeutics to Create Leading Company Developing Medicines Targeting Metalloenzymes

Blacksmith Medicines Announces Merger With Forge Therapeutics to Create Leading Company Developing Medicines Targeting Metalloenzymes - read this article along with other careers ...

@NatureBiotech shared
On Jan 3, 2023
@oncodeinstitute @_knaw @UMCUtrecht @ISTAustria @jakeyeung @AlexandervanOu1 New methods for research into chromatin #NBTintheNews via @_Hubrecht https://t.co/AypjE1p221
Open
New methods for research into chromatin

New methods for research into chromatin

Researchers from the lab of Alexander van Oudenaarden developed new methods to study chromatin in individual cells.

@Labiotech_eu shared
On Jan 1, 2023
Roquefort Therapeutics is developing first-in-class drugs in the oncology segment prior to partnering or selling to big pharma. 👇🏻 #biotech #lifesciences #news https://t.co/EfKzE5b77s
Open
Watch: Roquefort Therapeutics at BioFIT

Watch: Roquefort Therapeutics at BioFIT

Roquefort Therapeutics is developing first-in-class drugs in the oncology segment prior to partnering or selling to big pharma.

@BiotechWorld shared
On Jan 1, 2023
STEMCELL Technologies President and CEO Dr. Allen Eaves Appointed to the Order of Canada https://t.co/9SkFinY9VC
Open
STEMCELL Technologies President and CEO Dr. Allen Eaves Appointed to the Order of Canada

STEMCELL Technologies President and CEO Dr. Allen Eaves Appointed to the Order of Canada

STEMCELL Technologies President and CEO Dr. Allen Eaves Appointed to the Order of Canada - read this article along with other careers information, tips and advice on BioSpace

@pharmaphorum shared
On Jan 3, 2023
Another CEO change for @ReNeuronPLC as Catherine Isted departs, with executive chairman Iain Ross taking the helm and announcing a restructuring of the UK #biotech #RENE https://t.co/4CM3yK5yi2
Open
Restructuring announced at ReNeuron as another CEO resigns

Restructuring announced at ReNeuron as another CEO resigns

Another CEO change for ReNeuron as Catherine Isted departs, with executive chairman Iain Ross taking helm and announcing a restructuring

@biospace shared
On Jan 3, 2023
@AuriniaPharma has agreed to jointly file a motion with India's Sun Pharmaceuticals (Sun Pharma) to dismiss the inter parties review of patent No. 10,286,036. https://t.co/nkMvigIq4V #lifesciences #legal #biospace
Open
Aurinia and Sun Pharma File Joint Motion to Settle Patent Dispute

Aurinia and Sun Pharma File Joint Motion to Settle Patent Dispute

Aurinia and Sun Pharma agree to file a joint motion to dismiss a key patent dispute.

Read more:
weekly 04.01.2023
View archives
Back to home

Subscribe to Biotech - Companies & Industries.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Companies & Industries.
Privacy Policy

Sign up for the weekly Biotech - Companies & Industries newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Companies & Industries weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy